Perspectives in the treatment of pruritus

Focus on new strategies

H. L. Tey, Gil Yosipovitch

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Pruritus is a common symptom and the main source of morbidity in dermatologic diseases. Current management has been hampered by our inadequate understanding of the pathomechanisms of pruritus, but recent advances in elucidating the mediators, receptors and neuronal pathways hold promise for the development of new translational therapies. These mediators and receptors in the skin, peripheral nerves, spinal cord and brain form markers that drugs can be directed to inhibit via itch-transmitting pathways. Such targeted therapy is likely to be more effective and produce less side effects. Clinically, the treatment of pruritus should be tailored for different pruritic diseases, individualized for different patients and instituted early before the development of central sensitization. Chronic pruritus is a multidimensional problem and management requires a holistic approach, addressing the peripheral skin and neuronal pathologies, aberrant central processes and psychosocial factors.

Original languageEnglish (US)
Pages (from-to)115-121
Number of pages7
JournalDrugs of the Future
Volume36
Issue number2
DOIs
StatePublished - Jan 1 2011
Externally publishedYes

Fingerprint

Pruritus
Central Nervous System Sensitization
Skin
Therapeutics
Peripheral Nerves
Spinal Cord
Pathology
Psychology
Morbidity
Brain
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Perspectives in the treatment of pruritus : Focus on new strategies. / Tey, H. L.; Yosipovitch, Gil.

In: Drugs of the Future, Vol. 36, No. 2, 01.01.2011, p. 115-121.

Research output: Contribution to journalReview article

@article{0fda557164f642bcb9684272b2c7a937,
title = "Perspectives in the treatment of pruritus: Focus on new strategies",
abstract = "Pruritus is a common symptom and the main source of morbidity in dermatologic diseases. Current management has been hampered by our inadequate understanding of the pathomechanisms of pruritus, but recent advances in elucidating the mediators, receptors and neuronal pathways hold promise for the development of new translational therapies. These mediators and receptors in the skin, peripheral nerves, spinal cord and brain form markers that drugs can be directed to inhibit via itch-transmitting pathways. Such targeted therapy is likely to be more effective and produce less side effects. Clinically, the treatment of pruritus should be tailored for different pruritic diseases, individualized for different patients and instituted early before the development of central sensitization. Chronic pruritus is a multidimensional problem and management requires a holistic approach, addressing the peripheral skin and neuronal pathologies, aberrant central processes and psychosocial factors.",
author = "Tey, {H. L.} and Gil Yosipovitch",
year = "2011",
month = "1",
day = "1",
doi = "10.1358/dof.2011.036.02.1543303",
language = "English (US)",
volume = "36",
pages = "115--121",
journal = "Drugs of the Future",
issn = "0377-8282",
publisher = "Prous Science",
number = "2",

}

TY - JOUR

T1 - Perspectives in the treatment of pruritus

T2 - Focus on new strategies

AU - Tey, H. L.

AU - Yosipovitch, Gil

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Pruritus is a common symptom and the main source of morbidity in dermatologic diseases. Current management has been hampered by our inadequate understanding of the pathomechanisms of pruritus, but recent advances in elucidating the mediators, receptors and neuronal pathways hold promise for the development of new translational therapies. These mediators and receptors in the skin, peripheral nerves, spinal cord and brain form markers that drugs can be directed to inhibit via itch-transmitting pathways. Such targeted therapy is likely to be more effective and produce less side effects. Clinically, the treatment of pruritus should be tailored for different pruritic diseases, individualized for different patients and instituted early before the development of central sensitization. Chronic pruritus is a multidimensional problem and management requires a holistic approach, addressing the peripheral skin and neuronal pathologies, aberrant central processes and psychosocial factors.

AB - Pruritus is a common symptom and the main source of morbidity in dermatologic diseases. Current management has been hampered by our inadequate understanding of the pathomechanisms of pruritus, but recent advances in elucidating the mediators, receptors and neuronal pathways hold promise for the development of new translational therapies. These mediators and receptors in the skin, peripheral nerves, spinal cord and brain form markers that drugs can be directed to inhibit via itch-transmitting pathways. Such targeted therapy is likely to be more effective and produce less side effects. Clinically, the treatment of pruritus should be tailored for different pruritic diseases, individualized for different patients and instituted early before the development of central sensitization. Chronic pruritus is a multidimensional problem and management requires a holistic approach, addressing the peripheral skin and neuronal pathologies, aberrant central processes and psychosocial factors.

UR - http://www.scopus.com/inward/record.url?scp=84952981902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952981902&partnerID=8YFLogxK

U2 - 10.1358/dof.2011.036.02.1543303

DO - 10.1358/dof.2011.036.02.1543303

M3 - Review article

VL - 36

SP - 115

EP - 121

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 2

ER -